You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
綠葉製藥(02186.HK)向Exeltis授治療癡呆症貼劑墨西哥和波蘭獨家商業化權利
阿思達克 04-01 10:55
綠葉製藥(02186.HK)公布,集團全資附屬Luye Pharma Switzerland AG與與Exeltis Pharma Mexico, S.A de C.V和Exeltis Pharmaceuticals Holding, S.L訂立協定,Exeltis獲得新藥利斯的明多天透皮貼劑(或LY30410)在墨西哥和波蘭的獨家商業化權利。 利斯的明多天貼劑由集團開發,並已獲得多個歐洲國家的上市許可,用於治療與阿爾茲海默病相關的輕中度癡呆症。歐洲市場的銷售由集團的當地分支機搆和合作夥伴負責。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account